NEURO-ONCOLOGY CME CONFERENCE

Главная  /  Новости  /  NEURO-ONCOLOGY CME CONFERENCE

2nd Asia-Pacific Neuro-Oncology
CME Conference

August 3-7, 2020
Sheraton Maui Resort and Spa
Lahaina, Hawaii

Dear Colleague,

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, surgical and radiation management of adult and pediatric patients with primary and metastatic brain and spinal cord cancers. In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. The 2nd offering of the HMS Asia-Pacific Neuro-Oncology Conference, is a 5 day CME course designed to provide an international audience with a comprehensive update of the diagnosis and management of adult and pediatric patients with primary and metastatic brain and spinal cord tumors and neurologic complications of cancer. This course is targeted to health care specialists involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists).

For more information, visit the 2nd Asia-Pacific Neuro-Oncology CME Conference website.

Sincerely,
Tracy Batchelor, MD
Antonio Chiocca, MD, PhD
Jay Loeffler, MD
Patrick Wen, MD
Register Now

 

Call for Abstracts
The conference is accepting scientific abstract submissions. The deadline for submitting abstracts March 1st, 2020 by 11:59PM. Attendees will be given the option to submit an abstract at the time of registration for an additional $50 submission fee. Please click this link for information on abstract submission.

Please email abstracts to Michael Amato at mamato3@bwh.harvard.edu.
 

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management
This activity meets the criteria of Massachusetts Board of Registration in Medicine for 1.00 hour of Risk Management Study. This includes 1.00 credits of End-of-Life Care Studies. Please check your individual state licensing board requirements before claiming these credits.

Harvard Medical School  4 Blackfan Circle, 4th Floor  Boston,  MA   02115

You are receiving this email using data supplied by Medlist International in the belief that it will be of interest to you.
     ffffff-0.1 (2).png
To amend your details or areas of interest, please click here
If you do not wish to receive anything further, please click here